(Q33785375)

29 July 2017

1 reference

title

H1-receptor antagonists: safety issues (English)

1 reference

29 July 2017

Estelle F

1

1 reference

PubMed ID

10582735

29 July 2017

Simons R

series ordinal

2

1 reference

29 July 2017

1 November 1999

1 reference

Annals of Allergy, Asthma & Immunology

29 July 2017

1 reference

29 July 2017

83

1 reference

29 July 2017

5

1 reference

29 July 2017

481-488

1 reference

The pharmacology and use of H1-receptor-antagonist drugs

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

H1-receptor antagonists. Comparative tolerability and safety

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Effects of a single dose of loratadine on flying ability under conditions of simulated cabin pressure

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-94.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Acute effects of hydroxyzine on nocturnal sleep and sleep tendency the following day: A C-EEG study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Direct measurement of daytime sleepiness after administration of cetirizine and hydroxyzine with a standardized electroencephalographic assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Comparison of the central nervous system effects produced by six H1-receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Sedative effects and plasma concentrations following single doses of triazolam, diphenhydramine, ethanol and placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Sleepiness and performance during three-day administration of cetirizine or diphenhydramine.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Prolongation of simple and choice reaction times in a double-blind comparison of twice-daily hydroxyzine versus terfenadine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Acute and subchronic effects of the H1-histamine receptor antagonist ebastine in 10, 20 and 30 mg dose, and triprolidine 10 mg on car driving performance

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

The eternal triangle: benefit, risk, and cost of therapeutic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Mechanism of the cardiotoxic actions of terfenadine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Cardiac actions of antihistamines

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Torsades de pointes occurring in association with terfenadine use

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Astemizole-induced torsade de pointes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Risk of developing life-threatening ventricular arrhythmia associated with tefenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Use of terfenadine and contraindicated drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Temporal decline in filling prescriptions for terfenadine closely in time with those for either ketoconazole or erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Pharmacies and prevention of potentially fatal drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Grapefruit juice alters the systemic bioavailability and cardiac repolarization of terfenadine in poor metabolizers of terfenadine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Influence of itraconazole on the pharmacokinetics and electrocardiographic effects of astemizole

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Loratadine administered concomitantly with erythromycin: pharmacokinetic and electrocardiographic evaluations

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

The electrocardiographic effects of cetirizine in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Torsade de pointes with an antihistamine metabolite: potassium channel blockade with desmethylastemizole

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

Antihistamines and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962855-4

7 January 2021

10.1016/S1081-1206(10)62855-4

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10582735